Dapaglyn 10mg contains dapagliflozin 10mg, an SGLT2 inhibitor that acts at the kidneys. By reducing glucose reabsorption in the renal tubules, dapagliflozin increases urinary glucose excretion and lowers circulating blood glucose.

Its mechanism is independent of directly stimulating pancreatic insulin release. SGLT2 inhibitors can also have cardiovascular and kidney-related effects in appropriate patient populations, depending on the indication and individual clinical circumstances.

Brand: Dapaglyn

Active Ingredient: Dapagliflozin

Strength: 10mg

Form: Tablet

Pack: 10 tablets

Class: SGLT2 inhibitor

Use with appropriate medical monitoring and attention to hydration and other prescribed treatment measures.